Crispr Therapeutics AG's ticker is and the CUSIP is 417182108. A total of 1 filers reported holding Crispr Therapeutics AG in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $784,000 | -32.3% | 7,000 | -2.1% | 0.26% | -19.0% |
| Q2 2021 | $1,158,000 | +61.1% | 7,150 | +21.2% | 0.32% | +53.7% |
| Q1 2021 | $719,000 | -9.7% | 5,900 | +13.5% | 0.20% | -11.6% |
| Q4 2020 | $796,000 | +90.4% | 5,200 | +4.0% | 0.23% | +74.4% |
| Q3 2020 | $418,000 | +13.9% | 5,000 | 0.0% | 0.13% | +1.5% |
| Q2 2020 | $367,000 | +73.1% | 5,000 | 0.0% | 0.13% | +48.9% |
| Q1 2020 | $212,000 | -13.1% | 5,000 | +25.0% | 0.09% | -2.2% |
| Q4 2019 | $244,000 | – | 4,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FAIRFIELD, BUSH & CO. | 5,000 | $212,000 | 0.09% |